MBS Digest is a free weekly briefing on metabolic and bariatric surgery, obesity medicine, policy, and the GLP-1 market. It is written by practicing bariatric surgeons — with more than 25 years in the operating room — for the clinicians, specialists, and leaders who do this work.
Independent and free to read
Most newsletters in this space are owned by a vendor or paid for by health-industry advertisers. MBS Digest is not. We are editorially independent and reader-first, so the only thing shaping any given issue is what actually matters for your patients and your practice.
INDEPENDENT BY DESIGN
No health-industry ads. No society. No vendor.
✕
No health-industry ads
No ads from device, drug, or other health companies.
✕
No society ownership
Not owned or governed by a specialty society.
✕
No vendor funding
No device or drug company underwrites our conclusions.
To keep the Digest free, an issue may carry a small number of ads from companies outside health care. Those ads are identified as advertising and have no influence on what we cover. The details are on our Disclosures page.
Why that matters
No advertiser decides what we cover. No specialty society sets the agenda. No device or drug company underwrites the conclusions. When we flag a promising signal — or a real risk — you are getting an unfiltered read from people who understand the clinical stakes.
Who is behind it
MBS Digest is written and edited by practicing bariatric surgeons and metabolic specialists — not marketers. Meet the people who put it together on our editorial board.
Read it every week
One focused, independent briefing on metabolic and bariatric care — free, every week.